Dissecting the effects of lipopolysaccharides from nonlipopolysaccharide molecules in experimental porcine meningococcal sepsis

Critical Care Medicine

Volumn 38, Issue 6, 2010, Pages 1467-1474

  Hellerud, Bernt C ^a,c   Nielsen, Erik W ^e   Thorgersen, Ebbe B ^c   Lindstad, Julie K ^c   Pharo, Anne ^c   Tønnessen, Tor I ^d   Castellheim, Albert ^c   Mollnes, Tom E ^c   Brandtzaeg, Petter ^a,b  

^a Pediatric Department   (Norway)

^b Medical Biochemistry   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e NORDLAND HOSPITAL   (Norway)

Author keywords

Capillary leakage; Cytokines; Gramnegative sepsis; Lipopolysaccharide; Neisseria meningitidis; Shock

Indexed keywords

ALBUMIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL STUDY; GRAM NEGATIVE SEPSIS; HEART INDEX; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; IN VIVO STUDY; JEJUNUM BIOPSY; LACTATE BLOOD LEVEL; LEUKOPENIA; LUNG ARTERY PRESSURE; LUNG BIOPSY; MENINGOCOCCEMIA; MUSCLE BIOPSY; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWINE; SYSTEMIC VASCULAR RESISTANCE;

EID: 77953081837     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181de8c94     Document Type: Article

References (41)

1. Alexander C, Rietschel ET: Bacterial lipopoly-saccharides and innate immunity. J Endotoxin Res 2001; 7:167-202
2. Beutler B, Rietschel ET: Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 2003; 3:169-176
3. Kawai T, Akira S: TLR signaling. Semin Immunol 2007; 19:24-32
4. Tsujimoto H, Ono S, Efron PA, et al: Role of toll-like receptors in the development of sepsis. Shock 2008; 29:315-321
5. Steeghs L, den Hartog R, den Boer A, et al: Meningitis bacterium is viable without endotoxin. Nature 1998; 392:449-450
6. Brandtzaeg P: Host response to Neisseria meningitidis lacking lipopolysaccharides. Expert Rev Anti Infect Ther 2003; 1:589-596
7. Brandtzaeg P, Kierulf P, Gaustad P, et al: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204
8. Brandtzaeg P, Ovstebo R, Kierulf P: Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis 1992; 166:650-652
9. Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369:2196-2210
10. Brandtzaeg P, Bjerre A, Ovstebo R, et al: Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7:401-420
11. Bjerre A, Brusletto B, Ovstebo R, et al: Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. J Endotoxin Res 2003; 9:155-163
12. Sprong T, Stikkelbroeck N, van der Ley P, et al: Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 2001; 70: 283-288
13. Mogensen TH, Paludan SR, Kilian M, et al: Live Streptococcus pneumoniae, Haemophi-lus influenzae, and Neisseria meningitidis activate the inflammatory response through toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol 2006; 80: 267-277
14. Hellerud BC, Stenvik J, Espevik T, et al: Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and toll-like receptor activation. Infect Immun 2008; 76:4183-4189
15. Sprong T, Moller AS, Bjerre A, et al: Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun 2004; 72:3344-3349
16. Ingalls RR, Lien E, Golenbock DT: Membrane-associated proteins of a lipopolysac-charide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2. Infect Immun 2001; 69:2230-2236
17. Massari P, Visintin A, Gunawardana J, et al: Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol 2006; 176:2373-2380
18. Nielsen EW, Hellerud BC, Thorgersen EB, etal: A new dynamic porcine model of menin-gococcal shock. Shock 2009; 32:302-309
19. Steeghs L, de Cock H, Evers E, et al: Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J 2001; 20:6937-6945
20. Sprong T, Brandtzaeg P, Fung M, et al: Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood 2003; 102:3702-3710
21. Ovstebo R, Brandtzaeg P, Brusletto B, et al: Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42:2980-2987
22. Van Beaumont W: Evaluation of hemocon-centration from hematocrit measurements. J Appl Physiol 1972; 32:712-713
23. Barboni B, Turriani M, Galeati G, et al: Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 2000; 63:858-864
24. Saetre T, Lindgaard AK, Lyberg T: Systemic activation of coagulation and fibrinolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul Fibrinolysis 2000; 11: 433-438
25. Pickkers P, Sprong T, Eijk L, et al: Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005; 24:508-512
26. Hazelzet JA, Stubenitsky R, Petrov AB, et al: Cardiovascular aspects of experimental meningococcal sepsis in young and older awake piglets: Age-related differences. Shock 1999; 12:145-154
27. Benedict CR, Rose JA: Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992; 38:165-172
28. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
29. Pleiner J, Heere-Ress E, Langenberger H, et al: Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002; 22:95-100
30. Cohen RI, Shapir Y, Chen L, et al: Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med 1998; 26:738-747
31. Wanecek M, Rudehill A, Hemsen A, et al: The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med 1997; 25:848-857
32. Mercier JC, Beaufils F, Hartmann JF, et al: Hemodynamic patterns of meningococcal shock in children. Crit Care Med 1988; 16: 27-33
33. Bondestam J, Salven P, Jaaskela-Saari H, et al: Major surgery increases serum levels of vascular endothelial growth factor only temporarily. Am J Surg 2000; 179:57-59
34. Osterud B, Flaegstad T: Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb Haemost 1983; 49:5-7
35. Nieuwland R, Berckmans RJ, McGregor S, et al: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930-935
36. Brandtzaeg P: Pathogenesis and pathophysiology of meningococcal disease. In: Handbook of Meningococcal Disease. Frosch M, Maiden M (Eds). Weinheim, Germany, Wiley-VCH Verlag, 2006, pp 427-480
37. Brandtzaeg P, Joo GB, Brusletto B, et al: Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990; 57:271-278
38. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338
39. Moller AS, Bjerre A, Brusletto B, et al: Chemokine patterns in meningococcal disease. J Infect Dis 2005; 191:768-775
40. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, et al: Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172:433-439
41. Bjerre A, Brusletto B, Hoiby EA, et al: Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Grampositive septic shock. Crit Care Med 2004; 32:433-438